Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NEK2 pseudogene 1 (NEK2P1) is a pseudogene corresponding to the serine/threonine-protein kinase NEK2 gene. Pseudogenes like NEK2P1 are non-functional segments of DNA that resemble functional genes but do not encode an active protein product. There is no evidence in the literature that NEK2P1 is translated into a protein, plays a direct biological role, or serves as a therapeutic target. Most research and associations referenced in cancer, mitosis, and drug resistance concern the protein-coding NEK2 gene, not the NEK2P1 pseudogene[3][1][2][4][5]. Key clarification: The functional, biologically active kinase is encoded by NEK2, not NEK2P1. Reports about centrosome regulation, cancer, and drug resistance pertain to NEK2, not NEK2 pseudogene 1. NEK2P1 is not a therapeutic target and has no established roles as a biomarker, drug interactor, or disease effector.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NEK2 pseudogene 1 (NEK2P1).